FXR is a molecular target for the effects of vertical sleeve gastrectomy

Nature

Volumn 509, Issue 7499, 2014, Pages 183-188

  Ryan, Karen K ^a   Tremaroli, Valentina ^b   Clemmensen, Christoffer ^a,c   Kovatcheva Datchary, Petia ^b   Myronovych, Andriy ^d   Karns, Rebekah ^d   Wilson Pérez, Hilary E ^a   Sandoval, Darleen A ^a   Kohli, Rohit ^d   Bäckhed, Fredrik ^b,e   Seeley, Randy J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; FARSENOID X RECEPTOR; UNCLASSIFIED DRUG;

CHEMICAL BINDING; DIABETES; DIET; METABOLISM; MICROBIAL COMMUNITY; MOLECULAR ANALYSIS; OBESITY;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; GLUCOSE TOLERANCE; INTESTINE FLORA; MICROBIAL COMMUNITY; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SLEEVE GASTRECTOMY; VERTICAL SLEEVE GASTRECTOMY; WEIGHT REDUCTION;

ANIMALS; BARIATRIC SURGERY; BILE ACIDS AND SALTS; BODY COMPOSITION; CECUM; FEEDING BEHAVIOR; GASTRECTOMY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MALE; MICE; MICE, INBRED C57BL; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; STOMACH; WEIGHT LOSS;

EID: 84898051705     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13135     Document Type: Article

References (54)

1. Pories, W. J. Bariatric surgery: risks and rewards. J. Clin. Endocrinol. Metab. 93,S89-S96 (2008).
2. Schauer, P. R. et al. Bariatric surgery versus intensive medical therapy in obesepatients with diabetes. N. Engl. J. Med. 366, 1567-1576 (2012).
3. Wilson-Pérez, H. E. et al. Vertical sleeve gastrectomy is effective in two geneticmouse models of glucagon-like peptide-1 receptor deficiency. Diabetes 62,2380-2385 (2013).
4. Chambers, A. P. et al. Weight-independent changes in blood glucose homeostasisafter gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 141,950-958 (2011).
5. Karamanakos, S. N., Vagenas, K., Kalfarentzos, F. & Alexandrides, T. K. Weight loss,appetite suppression, and changes in fasting and postprandial ghrelin andpeptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: aprospective, double blind study. Ann. Surg. 247, 401-407 (2008).
6. Stefater, M. A., Wilson-Pérez, H. E., Chambers, A. P., Sandoval, D. A.&Seeley, R. J. Allbariatric surgeries are not created equal: insights from mechanistic comparisons.Endocr. Rev. 33, 595-622 (2012).
7. Jackness, C. et al. Very low-calorie diet mimics the early beneficial effect of Rouxen-Y gastric bypass on insulin sensitivity and b-cell function in type 2 diabeticpatients. Diabetes 62, 3027-3032 (2013).
8. Bradley, D. et al. Gastric bypass and banding equally improve insulin sensitivityand b cell function. J. Clin. Invest. 122, 4667-4674 (2012).
9. Myronovych, A. et al. Vertical sleeve gastrectomy reduces hepatic steatosis whileincreasing serum bile acids in a weight-loss-independent manner. Obesity 22,390-400 (2014).
10. Patti, M. E. et al. Serum bile acids are higher in humans with prior gastric bypass:potential contribution to improved glucose and lipid metabolism. Obesity 17,1671-1677 (2009).
11. Larsson, E. et al. Analysis of gut microbial regulation of host gene expression alongthe length of the gut and regulation of gut microbial ecology through MyD88. Gut61, 1124-1131 (2012).
12. Lhoste, E. F. et al. The human colonic microflora influences the alterations ofxenobiotic-metabolizing enzymes by catechins in male F344 rats. Food Chem.Toxicol. 41, 695-702 (2003).
13. Brodziak, F.,Meharg, C., Blaut, M.&Loh, G. Differences inmucosal gene expressionin the colon of two inbred mouse strains after colonization with commensal gutbacteria. PLoS ONE 8, e72317 (2013).
14. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in micelacking Toll-like receptor 5. Science 328, 228-231 (2010).
15. Kohli, R. et al. Weight loss induced by Roux-en-Y gastric bypass but notlaparoscopic adjustable gastric banding increases circulating bile acids. J. Clin.Endocrinol. Metab. 98, E708-E712 (2013).
16. Cummings, B. P. et al. Vertical sleeve gastrectomy improves glucose and lipidmetabolism and delays diabetes onset in UCD-T2DM rats. Endocrinology 153,3620-3632 (2012).
17. Gerhard, G. S. et al. A role for fibroblast growth factor 19 and bile acids in diabetesremission after Roux-en-y gastric bypass. Diabetes Care 36, 1859-1864 (2013).
18. Prawitt, J. et al. Farnesoid X receptor deficiency improves glucose homeostasis inmouse models of obesity. Diabetes 60, 1861-1871 (2011).
19. Chambers, A. P. et al. The effects of vertical sleeve gastrectomy in rodents areghrelin independent. Gastroenterology 144, 50-52.e5 (2013).
20. Ryan, K. K.,Woods, S. C.&Seeley, R. J. Central nervous systemmechanisms linkingthe consumption of palatable high-fat diets to the defense of greater adiposity. CellMetab. 15, 137-149 (2012)
21. Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102,11070-11075 (2005).
22. Parks, B. W. et al. Genetic control of obesity and gut microbiota composition inresponse to high-fat, high-sucrose diet in mice. Cell Metab. 17, 141-152 (2013).
23. Zhang, H. et al.Human gut microbiota inobesity andafter gastric bypass. Proc.NatlAcad. Sci. USA 106, 2365-2370 (2009).
24. Furet, J.-P. et al. Differential adaptation of human gut microbiota to bariatricsurgery-induced weight loss: links with metabolic and low-grade inflammationmarkers. Diabetes 59, 3049-3057 (2010).
25. Graessler, J. et al. Metagenomic sequencing of the human gut microbiome beforeand after bariatric surgery in obese patients with type 2 diabetes: correlation withinflammatory and metabolic parameters. Pharmacogenom. J. 13, 514-522(2012).
26. Liou, A. P. et al. Conserved shifts in the gut microbiota due to gastric bypass reducehost weight and adiposity. Sci. Transl. Med. 5, 178ra41 (2013).
27. Turnbaugh, P.J. et al. An obesity-associated gut microbiome with increasedcapacity for energy harvest. Nature 444, 1027-1031 (2006).
28. Turnbaugh, P. J.,Bäckhed, F., Fulton, L.&Gordon, J. I. Diet-induced obesity is linkedto marked but reversible alterations in the mouse distal gut microbiome. Cell HostMicrobe 3, 213-223 (2008).
29. Merritt, M. E. & Donaldson, J. R. Effect of bile salts on the DNA and membraneintegrity of enteric bacteria. J. Med. Microbiol. 58, 1533-1541 (2009).
30. Islam, K. B. M. S. et al. Bile acid is a host factor that regulates the composition of thececal microbiota in rats. Gastroenterology 141, 1773-1781 (2011).
31. Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing thelevels of tauro-b-muricholic acid, a naturally occurring FXR antagonist. Cell Metab.17, 225-235 (2013).
32. Swann, J. R. et al. Systemic gut microbial modulation of bile acid metabolism inhost tissue compartments. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4523-4530(2011).
33. Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparingmicrobial communities. Appl. Environ. Microbiol. 71, 8228-8235 (2005).
34. Dewulf, E. M. et al. Insight into the prebiotic concept: lessons from an exploratory,double blind intervention study with inulin-type fructans in obese women. Gut 62,1112-1121 (2013).
35. Wen, L. et al. Innate immunityandintestinalmicrobiota in the development of Type1 diabetes. Nature 455, 1109-1113 (2008).
36. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2diabetes. Nature 490, 55-60 (2012).
37. Karlsson, F. H. et al. Gut metagenome in European women with normal, impairedand diabetic glucose control. Nature 498, 99-103 (2013).
38. Neyrinck, A. M. et al. Dietary modulation of clostridial cluster XIVa gut bacteria(Roseburia spp.) by chitin-glucan fiber improves host metabolic alterationsinduced by high-fat diet in mice. J. Nutr. Biochem. 23, 51-59 (2012).
39. Ridaura, V. K. et al. Gut microbiota from twins discordant for obesity modulatemetabolism in mice. Science 341, 1241214 (2013).
40. Vrieze, A. et al. Transfer of intestinal microbiota fromlean donors increases insulinsensitivity in individuals with metabolic syndrome. Gastroenterology 143,913-6.e7 (2012).
41. Cariou, B. et al. The farnesoid X receptor modulates adiposity and peripheralinsulin sensitivity in mice. J. Biol. Chem. 281, 11039-11049 (2006).
42. Ma, K., Saha, P. K., Chan, L. & Moore, D. D. Farnesoid X receptor is essential fornormal glucose homeostasis. J. Clin. Invest. 116, 1102-1109 (2006).
43. Zhang, Y. et al. Activation of the nuclear receptor FXR improves hyperglycemia andhyperlipidemia in diabeticmice.Proc.NatlAcad. Sci.USA103,1006-1011(2006).
44. Porez, G., Prawitt, J., Gross, B. & Staels, B. Bile acid receptors as targets for thetreatment of dyslipidemia andcardiovascular disease. J. LipidRes.53, 1723-1737(2012).
45. Ma, Y., Huang, Y., Yan, L., Gao, M.& Liu, D. Synthetic FXR agonistGW4064 preventsdiet-induced hepatic steatosis and insulin resistance. Pharm. Res. 30, 1447-1457(2013).
46. Watanabe, M. et al. Lowering bile acid pool size with a synthetic farnesoid Xreceptor (FXR) agonist induces obesity and diabetes through reduced energyexpenditure. J. Biol. Chem. 286, 26913-26920 (2011).
47. Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J.&Schoonjans, K. Targeting bileacidsignalling formetabolic diseases.NatureRev. Drug Discov. 7,678-693(2008).
48. Miles, P. D., Barak, Y., He, W., Evans, R. M. & Olefsky, J. M. Improved insulinsensitivityin mice heterozygous for PPAR-c deficiency. J. Clin. Invest. 105,287-292 (2000).
49. Sinal, C. J. et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bileacid and lipid homeostasis. Cell 102, 731-744 (2000).
50. Caporaso, J. G. et al. QIIME allows analysis of high-throughput communitysequencing data. Nature Methods 7, 335-336 (2010).
51. Salonen, A. et al. Comparative analysis of fecal DNA extraction methodswith phylogenetic microarray: effective recovery of bacterial and archaealDNA using mechanical cell lysis. J. Microbiol. Methods 81, 127-134(2010).
52. Hamady, M., Walker, J. J., Harris, J. K., Gold, N. J. & Knight, R. Error-correctingbarcoded primers for pyrosequencing hundreds of samples inmultiplex. NatureMethods 5, 235-237 (2008).
53. Caporaso, J. G. et al. PyNAST: a flexible tool for aligning sequences to a templatealignment. Bioinformatics 26, 266-267 (2010).
54. Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree: computing large minimumevolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 26,1641-1650 (2009).